 |
|
|
| |
Preclinical characterization of ABI-4334, a novel,
highly potent core inhibitor for the treatment of chronic
hepatitis B virus infection
|
| |
| |
AASLD 2021 Nov 12-15
Xiang Xu, Michael Shen, Lida Guo, Ariel Tang, Nuruddin Unchwaniwala, Thilo J Heckrodt, Min Zhong, Michael A Walker, Michel Perron, William Delaney, Kathryn M Kitrinos
Assembly Biosciences, Inc., South San Francisco, CA, USA
|
| |
|
|
|
|
|
